Schwarz, Angelina
Möller-Hackbarth, Katja
Ebarasi, Lwaki
Unnersjö Jess, David
Zambrano, Sonia
Blom, Hans
Wernerson, Annika
Lal, Mark
Patrakka, Jaakko
Article History
Received: 1 November 2018
Accepted: 31 May 2019
First Online: 20 June 2019
Competing Interests
: The results presented in this paper have not been published previously in whole or part, except in abstract format. Mark Lal is employed by AstraZeneca. Jaakko Patrakka’s research is supported by AstraZeneca. The other authors, Angelina Schwarz, Katja Möller-Hackbarth, Lwaki Ebarasi, David Unnersjö Jess, Sonia Zambrano, Hans Blom and Annika Wernerson declare no competing interests.